KA1 (GRIK4) Rabbit Polyclonal Antibody
Rabbit Polyclonal Grik4 Antibody
Product Datasheet for 'TA306499'
|Applications||IF, IHC, WB|
|Recommend Dilution||WB: 0.5 - 2 ug/mL, ICC: 2.5 ug/mL, IF: 20 ug/mL|
|Reactivity||Human, Mouse, Rat|
|Immunogen||Grik4 antibody was raised against a 14 amino acid peptide near the amino terminus of the human Grik4.|
|Formulation||PBS containing 0.02% sodium azide.|
|Purification||Affinity chromatography purified via peptide column|
|Gene Name||glutamate ionotropic receptor kainate type subunit 4|
|Background||Grik4 codes for the KA1 subunit of kainate-type ionotropic glutamate receptors which are critical regulators of network activity that act by modifying neuronal excitability, directly and indirectly, through GABAergic interneurons. Five subunits can assemble to form kainate receptors (KARs): GluR5 (coded by Grik1), GluR6 (coded by Grik2), and GluR7 (coded by Grik3) are the low-affinity subunits, and KA1 and KA2 are the high-affinity subunits. In the adult brain, KARs are located pre- and postsynaptically on pyramidal cells and on interneurons. Kainate receptors on GABA-containing interneurons enhance GABA release and thereby downregulate glutamatergic signaling. KARs have been implicated in numerous psychiatric disorders. Case control studies show significant association of Grik4 with both schizophrenia and bipolar disorder. Despite its predicted molecular weight, Grik4 often migrates at a lower molecular weight in SDS-PAGE.|
|Synonyms||EAA1; GluK4; GRIK; KA1|
|Protein Families||Druggable Genome, Ion Channels: Glutamate Receptors, Transmembrane|
|Protein Pathways||Neuroactive ligand-receptor interaction|
*Delivery time may vary from web posted schedule. Occasional delays may occur due to unforeseen complexities in the preparation of your product. International customers may expect an additional 1-2 weeks in shipping.